Search Login Register

3-Tyr-octreotide Summary

Description: cyclic octapeptide analog of somatostatin; potent somatostatin agonist; RN given refers to (R-(R*,R*))-isomer; RN for cpd without isomeric designation not avail 3/90

Also Known As: (Tyr(3))octreotide; 204-090; SMS 201-995, Tyr(3)-; SMS 204-090; SMS-204-090 Show All >>

Networked: 35 relevant articles (2 outcomes, 9 trials/studies) for this Bio-Agent

Key Diseases for which 3-Tyr-octreotide is Relevant

  1. Neoplasms (Cancer) : 1 outcome 7 studies in 25 results
  2. Thyroid Neoplasms (Thyroid Cancer) : 1 outcome in 2 results
  3. Neoplasm Metastasis (Metastasis) : 2 studies in 3 results
  4. Neuroendocrine Tumors (Neuroendocrine Tumor) : 1 study in 4 results
  5. Carcinoid Tumor (Carcinoid) : 1 study in 2 results
Show All >>

Drugs Related to 3-Tyr-octreotide

  1. yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acid
  2. Somatostatin Receptors (Somatostatin Receptor)
  3. (DOTA(0)-Phe(1)-Tyr(3))octreotide (SMT 487)
  4. Octreotide (Sandostatin)
  5. Pentetic Acid (DTPA)
  6. Iodine
  7. Peptide Receptors (Peptide Receptor)
  8. Somatostatin (Somatotropin Release-Inhibiting Factor)
  9. Tyr(3)- octreotate
  10. EDDA (NiEDDA)
Show All >>

Therapies Related to 3-Tyr-octreotide

  1. Radiotherapy
  2. Intravenous Injections
  3. Injections

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.